Skip to main content

Day: August 12, 2020

DFDS Delårsrapport 2. kvt. 2020

Selskabsmeddelelse nr. 19/2020 HURTIGERE LØFT I EFTERSPØRGSEL END FORVENTET• Stigning i fragtmængder mod slutningen af 2. kvt. og i juli• God efterspørgsel fra passagerer på genåbnede ruter• Ekstraordinær negativ resultatpåvirkning fra passagerer i 2. kvt.• Forventning forbedret: Et EBITDA på DKK 2,2-2,5 mia. forventes nu for 2020 (før: Sandsynlig reduktion ned mod DKK 2 mia.) 2. KVT. 2020• Omsætning 34% ned til DKK 2,8 mia.• EBITDA 49% ned til DKK 507 mio.• Passageraktiviteter årsag til hovedparten af resultatnedgang FORVENTNING 2020• EBITDA på DKK 2,2-2,5 mia. Før: Sandsynlig reduktion ned mod DKK 2 mia. (2019: DKK 3,6 mia.)• Investeringer på omkring DKK 1,6 mia., uændret ”Vores fremtidsudsigt er forbedret. Fragtmængderne er stigende, og efterspørgslen efter færgerejser giver grund til en vis optimisme på vores genåbnede passagerruter....

Continue reading

TGS Announces New Onshore 3D Seismic Survey in the Powder River Basin

Oslo, Norway (12 August 2020) – TGS, a leading provider of multi-client geoscience data for exploration & production (E&P) companies, today announced Voyager 3D – a new multi-client U.S. onshore 3D seismic survey within the Powder River Basin.Voyager 3D, located in Johnson County, Wyoming, will encompass approximately 555 square kilometers. The high-resolution survey is ideally situated in the high potential trend to the north of the basin, where the prospective stratigraphic section of stacked reservoirs exceeds 5,000 feet in thickness.  Unconventional targets include two world-class source rocks, the Niobrara and Mowry, along with numerous historically productive formations including the upper and lower Cretaceous sandstones and the Pennsylvanian, that are now being exploited successfully with unconventional technologies.Permitting...

Continue reading

SIILI SOLUTIONS OYJ: PUOLIVUOSIKATSAUS 1.1.–30.6.2020 (tilintarkastamaton)

SIILI SOLUTIONS OYJ: PUOLIVUOSIKATSAUS 1.1.–30.6.2020 (tilintarkastamaton)SIILIN KANNATTAVA KASVU JATKUI KORONASTA HUOLIMATTASiili Solutions Oyj, puolivuosikatsaus, 12.8.2020 kello 8.45TAMMI–KESÄKUU 2020:Liikevaihto oli 44 021 (40 695) tuhatta euroaLiikevaihdon kasvu oli 3 326 tuhatta euroa eli 8,2 %, joka oli kokonaisuudessaan orgaanista kasvuaKäyttökate (EBITDA) oli 4 422 (3 537) tuhatta euroa, kasvua +25,0 %Käyttökate-% (EBITDA) oli 10,0 (8,7) % liikevaihdostaOikaistu liikevoitto (EBITA) oli 3 218 (2 589) tuhatta euroaOikaistu liikevoitto (EBITA) oli 7,3 (6,4) % liikevaihdosta, kasvua 24,3 %Liikevoitto (EBIT) oli 2 506 (1 877) tuhatta euroa, kasvua +33,5 %Katsauskauden tulos oli 4 499 (1 332) tuhatta euroa, kasvua + 237,8 %Osakekohtainen tulos oli 0,64 (0,19) euroa, kasvua +237,8 %Liiketoiminnan rahavirta oli 4 458 (1 771) tuhatta...

Continue reading

Six-month interim report (Q2) 2020

ALK upgrades earnings outlook (unaudited)ALK’s overall sales in the Q2 low-season were in line with expectations given the COVID-19 pandemic, with tablet sales up 25%. Sublingual, home-based treatments in Europe and International markets were resilient to the impact of the pandemic, whereas sales of SCIT products, and sales in the USA, were most affected. In Q2, ALK saw earnings increase by 213% on the back of savings and delayed R&D expenditure.Q2 2020 highlightsTotal revenue at DKK 772 million (785), showed zero growth in local currencies. Planned product discontinuations reduced growth by approximately 3 p.p. Currencies reduced reported growth by 1 p.p.Tablets saw growth of 25% to DKK 324 million (263), while combined SCIT and SLIT-drops sales were down 14% on the effects of COVID-19 and portfolio rationalisation.Operating profit...

Continue reading

Six-month interim report (Q2) 2020

Bemærk venligst, at rapporten udelukkende findes på engelskALK upgrades earnings outlook (unaudited)ALK’s overall sales in the Q2 low-season were in line with expectations given the COVID-19 pandemic, with tablet sales up 25%. Sublingual, home-based treatments in Europe and International markets were resilient to the impact of the pandemic, whereas sales of SCIT products, and sales in the USA, were most affected. In Q2, ALK saw earnings increase by 213% on the back of savings and delayed R&D expenditure.Q2 2020 highlightsTotal revenue at DKK 772 million (785), showed zero growth in local currencies. Planned product discontinuations reduced growth by approximately 3 p.p. Currencies reduced reported growth by 1 p.p.Tablets saw growth of 25% to DKK 324 million (263), while combined SCIT and SLIT-drops sales were down 14% on the effects...

Continue reading

TRAINERS’ HOUSE -KONSERNIN PUOLIVUOSIKATSAUS 1.1.–30.6.2020

TRAINERS’ HOUSE OYJ, PUOLIVUOSIKATSAUS 12.8.2020 klo 8:30liikevaihto 5,0 milj. euroa (6,2 milj. euroa), muutos -18,7 % edellisen vuoden vastaavaan kauteen verrattunaoperatiivinen liiketulos 0,6 milj. euroa (1,0 milj. euroa), 12,0 % liikevaihdosta (15,9 %)tehtyjen liikearvotestien perusteella lasketut käyttöarvot alittivat kirjanpitoarvon, mikä johti tavaramerkkien 5,1 milj. euron arvonalentumiskirjaukseen ja yrityskaupan laskennallisen verovelan 1,0 miljoonan euron pienenemiseen kesäkuussa 2020. Alaskirjaus aiheutuu vanhakantaisen valmennusliiketoiminnan heikentyneestä näkymästä ja diskonttokorkona käytetyn painotetun keskimääräisen pääomakustannuksen (WACC)noususta.liiketulos -4,5 milj. euroa (1,0 milj. euroa), -89,9 % liikevaihdosta (15,9 %)liiketoiminnan rahavirta 1,5 milj. euroa (1,3 milj. euroa)osakekohtainen tulos -0,16 euroa (0,05...

Continue reading

How to Purchase Your Own Dream Bike on EMI

Have you been eyeing a bike for a long time? Stop dreaming about it and make it yours. Now, you can own a bike without hurting your wallet. Hero FinCorp offers a loan for the purchase of a bike on EMI, which makes bike financing easy and simple. Irrespective of the type and brand of bike you wish to own, Hero FinCorp can turn your dream into a reality. You need to start by shortlisting the bikes you wish to purchase. You can then take a test drive in them and decide whether the bike is ideal for you or not. The loan is available for economy bikes as well as sports bikes. If you are someone who likes to go on adventures in the hills, choose a high capacity bike. And if you are purchasing only for your daily commute, simply choose an economy model that has all the features you are looking for. Hero FinCorp is one of the most reliable and...

Continue reading

Investam-HK: Nasdaq fell short back to 10,000 while Gold remained strong, other major indices are up

Stocks rallied mixed this Monday session as investors focus on the reports of positive earnings results and upcoming government’s stimulus package. Nasdaq however lost its pace and is down again at 10k range. Major contributors of the dipped are tech giants Microsoft and Facebook who slid around 2% while Amazon fell by 0.6%. Gold index is down for four consecutive days now but remained at $2,000 an ounce while crude oils are up. Here are the main movements from the Global market; Stocks – The Dow Jones Industrial Average advances with 357 points change or 1.3% closing its price around 27,791.44. Its 6th day positive gained for this month.– The S&P 500 climbed up with 0.3% to 3,360.47, just as the market closed by 4:00 in the afternoon New York time.– Nasdaq Composite fell big time losing about 0.4% down to 10,968.36.–...

Continue reading

Kuros Biosciences Reports Results for First Half 2020

  Financial and Operational HighlightsCHF 16.0 million cash & cash equivalents, trade and other receivables as at June 30, 2020Revenues increased to CHF 1.3 million driven by strong MagnetOs sales, up 42% versus H1 2019Net operating costs of CHF 7.5 million led by higher marketing expensesSeveral trial sites activated for the Fibrin-PTH phase II clinical study, ready to enroll patientsStrengthened Fibrin-PTH IP estate with U.S. patent covering PTH containing matrices for spinal fusionMagnetOs preclinical data demonstrate superiority to market-leading synthetic bone grafts in spinal fusionPositive clinical outcomes from investigator-led clinical study of MagnetOsZURICH, Switzerland, Aug. 12, 2020 (GLOBE NEWSWIRE) — Kuros Biosciences, a leader in next generation bone graft technologies, today reported its results for the first...

Continue reading

Addex Reports 2020 Half Year Financial Results and Provides Corporate Update

Geneva, Switzerland, August 12, 2020 – Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today reported its second quarter and half year financial results for the periods ended June 30, 2020 and provided an update on corporate activities.H1 2020 Operating Highlights:

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.